Natera (NTRA) Q4 Earnings: What To Expect
Genetic testing company Natera (NASDAQ:NTRA). will be announcing earnings results tomorrow after market close. Here’s what to ...
Natera Inc (NTRA) Q4 2024 Earnings Report Preview: What To Expect
Natera Inc (NASDAQ:NTRA) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue ...
Business Wire22h
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict
The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high- ...
MLB 26-and-under power rankings: Evaluating the young talent in all 30 organizations
Yahoo Sports’ 26-and-under power rankings are a remix on the traditional farm system rankings that assess the strength of MLB ...
360dx23h
Natera MRD Test Receives MolDx Coverage for Lung Cancer Surveillance
The test has met coverage requirements for use with patients with non-small cell lung cancer with resectable or unresectable disease in the surveillance setting.
lifesciencesipreview21h
Natera loses $96m jury win as judge invalidates DNA test patents
Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing ...